Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA
Sao Paulo, SP, Brazil
Hospital in São Paulo, State of São Paulo
Av. Conselheiro Rodrigues Alves, 820 - Vila Mariana, São Paulo - SP, 04014-002
About Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA
"A Unidade da Vila Mariana (região centro-sul da capital) conta com uma estrutura de 8 andares e tem a capacidade de realizar em torno de 5,5 mil consultas oncológicas do SUS por mês. A ampliação do São Camilo Oncologia na Vila Mariana contempla o atendimento oncológico ambulatorial, além de especialidades de apoio que envolve o cirúrgico ambulatorial e outros Serviços Auxiliares de Diagnóstico e Tratamento (SADT). *Como você pode ser atendido: A unidade atende por meio de convênio com a prefeitura de São Paulo, que encaminha os pacientes da rede básica com diagnóstico de câncer via agenda regulada para unidades oncológicas da cidade, sendo a Unidade da Vila Mariana uma referência."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA
During the past decade, Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on
average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
2006-06-01
2011-07-01
Completed
41
S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
2007-03-01
2014-01-01
Completed
85
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
2007-07-01
2014-01-01
Completed
89
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
2008-03-01
2014-02-25
Completed
134
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA
According to Clinical.Site data, the most researched conditions in "Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA" are
"Breast Cancer" (1 trials), "Early Breast Cancer" (1 trials), "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials), "HER2-Positive Early Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA" in a lesser frequency.
Clinical Trials Intervention Types at Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA
Most popular intervention types in "Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA" are "Drug" (8 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Placebo" (3 trials), "Giredestrant" (2 trials), "Trastuzumab" (2 trials) and "Trastuzumab Emtansine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA
The vast majority of trials in "Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA" are
7 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA
Currently, there are NaN active trials in "Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".